1,000
Participants
Start Date
April 30, 2008
Targeted Renal Therapy
Patient diagnosis, treatment, and follow-up are left to the discretion of the participating investigator. There are no requisites as to how patients should be managed as this is intended to be an observational study. No procedures other than usage of the Benephit Infusion System per its Instructions for Use are specifically required for participation in this study.
Owensboro Heart & Vascular, Owensboro
Cardiovascular Institute of the South, Lafayette
Scripps Clinic, La Jolla
Providence Heart & Vascular, Portland
Lead Sponsor
FlowMedica, Inc.
INDUSTRY